Edition:
United States

Aeglea Bio Therapeutics Inc (AGLE.OQ)

AGLE.OQ on NASDAQ Stock Exchange Global Market

9.16USD
20 Aug 2018
Change (% chg)

$-0.04 (-0.43%)
Prev Close
$9.20
Open
$9.37
Day's High
$9.37
Day's Low
$8.99
Volume
60,719
Avg. Vol
80,407
52-wk High
$12.00
52-wk Low
$2.95

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.47 December 21 Aug 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 4 4 4 3
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.67 1.67 1.67 1.60

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 4 1.08 1.50 0.00 0.00
Quarter Ending Dec-18 4 1.08 1.50 0.00 0.00
Year Ending Dec-18 4 5.29 6.90 3.89 1.95
Year Ending Dec-19 6 2.03 6.40 0.00 6.01
Earnings (per share)
Quarter Ending Sep-18 4 -0.47 -0.41 -0.53 -0.55
Quarter Ending Dec-18 4 -0.46 -0.35 -0.53 -0.56
Year Ending Dec-18 4 -1.88 -1.77 -2.01 -2.21
Year Ending Dec-19 5 -2.28 -1.43 -3.76 -2.52

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 1.63 2.38 0.74 45.50
Quarter Ending Mar-18 1.60 1.51 0.09 5.63
Quarter Ending Dec-17 1.16 1.48 0.32 27.34
Quarter Ending Sep-17 1.09 1.26 0.17 15.95
Quarter Ending Jun-17 1.29 1.48 0.19 14.87
Earnings (per share)
Quarter Ending Jun-18 -0.38 -0.46 0.08 -22.34
Quarter Ending Mar-18 -0.44 -0.49 0.05 -12.00
Quarter Ending Dec-17 -0.53 -0.38 0.15 -27.76
Quarter Ending Sep-17 -0.55 -0.48 0.07 -12.73
Quarter Ending Jun-17 -0.48 -0.47 0.01 -2.08

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 1.08 1.16 1.16 1.16 0.00
Quarter Ending Dec-18 1.08 1.16 1.16 1.16 0.00
Year Ending Dec-18 5.29 5.25 5.46 5.46 1.95
Year Ending Dec-19 2.03 1.96 2.35 2.35 6.01
Earnings (per share)
Quarter Ending Sep-18 -0.47 -0.44 -0.39 -0.39 -0.55
Quarter Ending Dec-18 -0.46 -0.43 -0.39 -0.39 -0.56
Year Ending Dec-18 -1.88 -1.79 -1.63 -1.63 -2.21
Year Ending Dec-19 -2.28 -2.28 -2.28 -2.28 -2.52

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 1 0 3 1
Year Ending Dec-19 1 0 1 0
Earnings
Quarter Ending Sep-18 0 0 1 3
Quarter Ending Dec-18 0 0 1 3
Year Ending Dec-18 0 0 0 4
Year Ending Dec-19 0 0 1 2